WO2014076533A1 - Composition of a cleansing foam based on natural extracts for the cleansing of the anal area - Google Patents

Composition of a cleansing foam based on natural extracts for the cleansing of the anal area Download PDF

Info

Publication number
WO2014076533A1
WO2014076533A1 PCT/IB2013/002476 IB2013002476W WO2014076533A1 WO 2014076533 A1 WO2014076533 A1 WO 2014076533A1 IB 2013002476 W IB2013002476 W IB 2013002476W WO 2014076533 A1 WO2014076533 A1 WO 2014076533A1
Authority
WO
WIPO (PCT)
Prior art keywords
composition
cleansing
quantity comprised
glycolic extract
escin
Prior art date
Application number
PCT/IB2013/002476
Other languages
French (fr)
Inventor
Vincenzo Russo
Original Assignee
Vi.Rus Srl Unipersonale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vi.Rus Srl Unipersonale filed Critical Vi.Rus Srl Unipersonale
Publication of WO2014076533A1 publication Critical patent/WO2014076533A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534Mentha (mint)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/155Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/73Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736Prunus, e.g. plum, cherry, peach, apricot or almond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/046Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/345Alcohols containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/43Guanidines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • A61K8/602Glycosides, e.g. rutin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/005Preparations for sensitive skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/10Washing or bathing preparations

Definitions

  • the present invention concerns the realization of a new formulation in the form of foam with soothing, protective and refreshing action which allows a gentle cleansing, without rubbing, of the anal mucosa.
  • Such formulation is characterized by the association of bisabolol, escin, Calendula officinalis glycolic extract, Centella asiatica glycolic extract, sweet almond oil, glycerin, sodium lauroyl sarcosinate, cocamidopropyl hydroxysultaine, sodium cocoamphoacetate, menthyl lactate, peppermint essential oil, chlorhexidine digluconate, PEG- 12 dimethicone, citric acid, mixture of n-butane, isobutane and propane, water.
  • hemorrhoidal disease accounts for over 90% of the problems related to the repairing process of the ano-rectal canal.
  • hemorrhoids refers to the abnormal swelling of the hemorrhoidal veins, which are proximal to the anus.
  • Hemorrhoids are one of the most common diseases and, despite being completely benign, they can cause discomforts which can limit the daily activities. They are more common in civilized countries, where an estimated 4-5 people out of 100 suffer from it; between 45 and 65 years hemorrhoids are more common and they affect 1 person out of 2.
  • This disorder mainly affects pregnant women; in fact, during pregnancy the weakness of the tissues due to the hormonal changes of gestation, the increased pressure on the abdomen from the enlarging uterus and increased blood flow may easily result in hemorrhoids.
  • hemorrhoids may be a secondary manifestation of more serious diseases.
  • This disorder is mainly caused by the need and habit of "emptying" the rectal ampulla, the natural container of stools, only when there is the condition for doing it.
  • This mechanism causes an overload of the anal region, worsened by the force of gravity, and then the stagnation of blood in the hemorrhoidal veins. If the tissue surrounding these veins is not sufficiently stable, the veins can also break down and slide downwards , up to developing the hemorrhoids.
  • the main symptoms are:
  • Hemorrhoids are classified according to the degree of bleeding and severity of prolapse, in particular:
  • First-degree hemorrhoids they are completely internal in the anal canal . They may bleed, but do not protrude outside, even during exertion or emission of stools.
  • Second-degree hemorrhoids they have an increased volume resulting from the increased venous pressure caused by a muscular strain. They tend to come out (prolapse) from the anal canal, but they reduce and retract spontaneously in the canal when the stimulus is over.
  • Third-degree hemorrhoids they prolapse outside spontaneously or under strain and must be pushed back into the anal canal by hand.
  • Fourth-degree hemorrhoids they are permanently prolapsed outside and they can no longer be pushed back by hand.
  • hemorrhoids have complications such as:
  • Hemorrhoids are an anatomical alteration, and as such they can't be completely eliminated with medicines only.
  • the drugs used both locally and systemically, can keep the situation under control and reduce the risk of complications, but they can't correct the structural modification of the veins. Therefore, the treatment should be chosen on a case by case basis, according to the condition.
  • ointments, gels or ointments containing lubricants and emollients decreasing the mechanical strain during defecation can be useful, but also containing anaesthetics to relieve the pain.
  • they may be associated with drugs for the venous circulation, in order to reinforce the walls and, if necessary, with derivatives of cortisone, in order to control the inflammation associated with the venous swelling.
  • Proctitis may have an unknown etiology (eg., ulcerative proctitis or Crohn's disease) or can result from sexually transmitted diseases or other infections (eg., Campylobacter, Shigella, Salmonella).
  • the patient suffers from rectal bleeding or secretion of mucus often associated with anorectal pain, symptoms of an inflamed 100 rectal mucosa.
  • Criptits are another less common pathology, which causes pain in the anal area during evacuation.
  • Anal fissure is a small "nick" on the homonym opening, due to excessive dilation during the passage of stools.
  • the presence of many nerve endings makes this 105 disorder particularly irritating and painful. The pain typically begins during or immediately after defecation, lasts for several hours and then ceases until the following evacuation.
  • the perianal fistulas consists in the formation of a tube-shaped canal that opens 1 10 between the anal canal on one side and, usually, the perianal skin on the other side.
  • composition object of the invention is proposed in the form of rinse-off foam for 1 15 topical use, indicated for the daily cleansing of the anal mucosa in particular after surgical interventions and/or in the presence of proctological diseases in order to maintain a proper hygiene in the area.
  • liquid soaps on the market in order to carry out their cleansing action, must be applied by the user through a mechanical rubbing action on the inflamed and
  • the foam formulation object of this invention is dispensed directly on the anal mucosa and it carries out its cleansing action by staying in place for about 30 seconds with no need to rub. Consequently, the formulation gently cleanses the inflamed surface and carries out a refreshing action
  • Bisabolol one of the most important active ingredients of camomile (Matricaria recutita), has known calming and soothing properties (Guy P.P. Kamatou, Alvaro M. Viljoen. A review of the application and pharmacological properties of bisabolol and 130 bisabolol-rich ils. Journal of the American Oil Chemists ' Society, Volume 87, Issue 1, January 2010, Pages 1-7).
  • Escin is a mixture of saponins (terpene glycosides) extracted from the Aesculus hippocastanum with soothing, anti-edemigenous and vasoprotective action (A. Bruni. Farmacognosia Generale e Applicata. Piccin Nuova Libraria, 1999, p.339).
  • escin reduces the exudation, by limiting the extravasation of liquids in the tissue and by accelerating the absorption of the exiting edema.
  • Escin increases the resistance of the involved capillaries, by changing their permeability, thereby reducing the passage of
  • the ⁇ -escin in particular, is considered the main molecule responsible for the vasoprotective effects with a trophic effect on the microcirculation (Cesare R. Sirtori. Aescin: pharmacology, pharmacokinetics and therapeutic profile. Pharmacological Research Volume 44, Issue 3, September 2001, Pages 183-193).
  • the extract of Calendula officinalis is rich in triterpenes, flavonoids, polysaccharides, carotenes and phytosterols. It has remarkable soothing properties thanks to its unsaponifiable component constituted by flavonoids and mucilages.
  • the active ingredients of the extract of Calendula officinalis, the flavonoids in particular have a soothing effect on the inflamed and sensitive skin, stimulate the re-
  • Centella asiatica 160 improves the microcirculation, capillary flow and vascular tone, and reinforces the connective tissue of the perivascular amorphous substrate even in the case of hemorrhoids (MacKay D. Hemorrhoids and varicose veins: a review of treatment options. Alternative Medicine Review: a Journal of Clinical Therapeutic 2001, 6(2): 126-140).
  • Sweet almond oil contains many vitamins (A and B), carbohydrates, proteins and minerals, and has emollient, softening, soothing and nourishing properties. It is useful for softening the skin, for the treatment of redness and cracking, for the protection of the delicate skin and for helping to reduce the scars (Ahmad Z. The uses and properties of almond oil. Plastic and Reconstructive Surgery, Salisbury General 170 Hospital, Salisbury, Wiltshire, UK. Complement Ther Clin Pract. 2010 Feb; 16(1): 10-2).
  • Sodium lauroyl sarcosinate also known as sarkosyl
  • sarkosyl is an anionic surfactant with excellent cleaning properties (Lu Yun Chen Yanni Wu Hao Xiao Shenxiu. Sodium Lauroyl Sarcosinate. Fine and Specialty Chemicals 2001 -13).
  • Cocamidopropyl hydro ysultaine and sodium cocoamphoacetate both belong to the class of amphoteric surfactants. This type of surfactants have less cleansing power and less foaming characteristics than the other types of surfactants, but they are less aggressive and are irritating in a limited way (Blake-Has kins, JC, Scala, D, Rhein, LD, Robbins, CR. Predicting surfactant irritation from swelling response of a
  • Cocamidopropyl hydroxysultaine is used as a foam booster, viscosity builder and antistatic agent (Guin JD. Reaction to cocamidopropyl hydroxysultaine, an amphoteric surfactant and conditioner. Contact Dermatitis 42 (5): 284, 2000).
  • Sodium cocoamphoacetate derived from coconut oil, has a foam booster and
  • conditioning power Thanks to its sweetness and its ability to promote the "sliding" of the product on the skin, it makes the product more easy to apply and rinse.
  • Menthyl lactate is an ester obtained from two molecules of natural origin, menthol and lactic acid.
  • menthol stimulates the cold receptors of the skin.
  • the peppermint oil is used, in association with methyl lactate, because of its delicate 200 refreshing action (Damonte SP, Selem C, Parente ME, Ares G, Manzoni AV.
  • Chlorhexidine digluconate carries out a preservative action thanks to its antiseptic, disinfectant, bacteriostatic and fungistatic properties. Chlorhexidine digluconate is a 205 good alternative to the available antiseptics for the skin, since it has a fast broad- spectrum antimicrobial action, with an extremely low potential to stimulate the skin reactions ⁇ Rosenberg A, Alatary SD, Peterson AF. Safety and efficacy of the antiseptic chlorhexidine gluconate. Surgery, Gynecology & Obstetrics 1976, 143(5): 789-92).
  • the foam formulation is dispensed through the help of a gas mixture (n-butane, isobutane, propane), which allows the application of the product directly on the area to be cleansed, with no need to touch the inflamed and/or damaged surface.
  • a gas mixture n-butane, isobutane, propane
  • composition in the form of rinse-off foam for topical use indicated for the cleansing of the anal mucosa contains the following substances:
  • Centella asiatica glycolic extract 0.01% of sweet almond oil

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Cosmetics (AREA)
  • Detergent Compositions (AREA)

Abstract

Composition in the form of rinse-off foam for the cleansing of the anal mucosa in the presence of proctologic pathologies and/or after surgical interventions. The composition comprises bisabolol in a quantity between 0.05% and 0.5%, escin in a quantity between 0.01 % and 0.5%, Calendula officinalis glycolic extract in a quantity between 0.1% and 5.0%, Centella asiatica glycolic extract in a quantity between 0.1 % and 10%, sweet almond oil in a quantity between 0.005%) and 0.2%, menthyl lactate in a quantity between 0.01% and 0.5%, peppermint essential oil in a quantity between 0.05% and 0.5%, chlorhexidine digluconate in a quantity between 0.1%) and 1%, glycerin in a quantity between 0.1% and 10%. Liquid soaps on the market, in order to carry out their cleansing action, must be applied by the user through a mechanical rubbing action on the inflamed and injured mucosa. This rubbing action turns out to be painful. The composition object of the invention is directly dispensed on the anal mucosa through the help of a gas mixture and cleans by staying in place for about 30 seconds, with no need to rub.

Description

DESCRIPTION
Attached to a patent application for INDUSTRIAL INVENTION entitled:
COMPOSITION OF A CLEANSING FOAM BASED ON NATURAL
EXTRACTS FOR THE CLEANSING OF THE ANAL AREA
*****
TECHNICAL FIELD
The present invention concerns the realization of a new formulation in the form of foam with soothing, protective and refreshing action which allows a gentle cleansing, without rubbing, of the anal mucosa. Such formulation is characterized by the association of bisabolol, escin, Calendula officinalis glycolic extract, Centella asiatica glycolic extract, sweet almond oil, glycerin, sodium lauroyl sarcosinate, cocamidopropyl hydroxysultaine, sodium cocoamphoacetate, menthyl lactate, peppermint essential oil, chlorhexidine digluconate, PEG- 12 dimethicone, citric acid, mixture of n-butane, isobutane and propane, water.
BACKGROUND ART
The hemorrhoidal disease accounts for over 90% of the problems related to the repairing process of the ano-rectal canal. The word hemorrhoids refers to the abnormal swelling of the hemorrhoidal veins, which are proximal to the anus. Hemorrhoids are one of the most common diseases and, despite being completely benign, they can cause discomforts which can limit the daily activities. They are more common in civilized countries, where an estimated 4-5 people out of 100 suffer from it; between 45 and 65 years hemorrhoids are more common and they affect 1 person out of 2. This disorder mainly affects pregnant women; in fact, during pregnancy the weakness of the tissues due to the hormonal changes of gestation, the increased pressure on the abdomen from the enlarging uterus and increased blood flow may easily result in hemorrhoids.
In rare cases, however, hemorrhoids may be a secondary manifestation of more serious diseases.
This disorder is mainly caused by the need and habit of "emptying" the rectal ampulla, the natural container of stools, only when there is the condition for doing it. This mechanism causes an overload of the anal region, worsened by the force of gravity, and then the stagnation of blood in the hemorrhoidal veins. If the tissue surrounding these veins is not sufficiently stable, the veins can also break down and slide downwards , up to developing the hemorrhoids.
The main symptoms are:
• Sensation of heaviness and discomfort in the anal area, associated with difficulty in evacuation.
• Tenesmus, that is the sensation of a desire to defecate when the defecation has been completed.
• Loss of blood in the hemorrhoids. It mostly appears at a later time when the sensation of swelling near the anus has already come out. The bleeding associated with hemorrhoids is generally very limited, and it occurs after the evacuation.
· Severe pain. This should lead to think that the situation is worsening, because normally the pain is almost completely absent and when it appears it is an indication of a hemorrhoidal "crisis". This condition is due to the protrusion of • the swelling veins through the anal canal. When this happens, the "swollen" veins are compressed by the anal sphincter, and thus they cause pain. The aggravation may also cause complications, which may be potentially very serious, such as the "throttling" of hemorrhoids.
Hemorrhoids are classified according to the degree of bleeding and severity of prolapse, in particular:
• First-degree hemorrhoids: they are completely internal in the anal canal . They may bleed, but do not protrude outside, even during exertion or emission of stools.
Generally, at this stage, they do not cause discomfort and pain.
• Second-degree hemorrhoids: they have an increased volume resulting from the increased venous pressure caused by a muscular strain. They tend to come out (prolapse) from the anal canal, but they reduce and retract spontaneously in the canal when the stimulus is over.
• Third-degree hemorrhoids: they prolapse outside spontaneously or under strain and must be pushed back into the anal canal by hand.
• Fourth-degree hemorrhoids: they are permanently prolapsed outside and they can no longer be pushed back by hand.
At this stage the pain and other symptoms are very distressing and they affect the quality of life of the person who suffer from them.
Frequently, hemorrhoids have complications such as:
• chronic constipation, due to an attempt to avoid discomfort during defecation;
• itching in the anus, due to local circulatory problems. Sometimes the circulatory difficulties may contribute to the onset of small eczema around the anal area.
Hemorrhoids are an anatomical alteration, and as such they can't be completely eliminated with medicines only. The drugs, used both locally and systemically, can keep the situation under control and reduce the risk of complications, but they can't correct the structural modification of the veins. Therefore, the treatment should be chosen on a case by case basis, according to the condition.
Generally, in the early stages, a regular application of ointments, gels or ointments containing lubricants and emollients decreasing the mechanical strain during defecation can be useful, but also containing anaesthetics to relieve the pain. In addition, they may be associated with drugs for the venous circulation, in order to reinforce the walls and, if necessary, with derivatives of cortisone, in order to control the inflammation associated with the venous swelling. Through this medical approach, and by paying close attention to the hygiene, it is possible to delay the need for surgical treatment which is the treatment of choice for third and fourth degree hemorrhoids, while first and second degree hemorrhoids (and the third degree waiting for a decisive operation), which are, by the way, the most common forms of clinical observation, are well suitable for medical treatment.
The usual hygienic-dietetic measures, such as the introduction of fiber and liquids in the diet associated with a proper local hygiene, should be recommended together with the pharmacological treatment.
In association with the topical or systemic drugs, it is useful to maintain a proper local hygiene through the use of cleansers containing active substances to be applied directly in the area to be treated in order to soothe and refresh the inflamed area. Proctitis, cnptitis, anal fissures, fissures, perianal fistulas are others and less common 95 proctologic diseases.
Proctitis may have an unknown etiology (eg., ulcerative proctitis or Crohn's disease) or can result from sexually transmitted diseases or other infections (eg., Campylobacter, Shigella, Salmonella). The patient suffers from rectal bleeding or secretion of mucus often associated with anorectal pain, symptoms of an inflamed 100 rectal mucosa.
Criptits are another less common pathology, which causes pain in the anal area during evacuation.
Anal fissure is a small "nick" on the homonym opening, due to excessive dilation during the passage of stools. Here, the presence of many nerve endings makes this 105 disorder particularly irritating and painful. The pain typically begins during or immediately after defecation, lasts for several hours and then ceases until the following evacuation.
An aggravation of the anal fissure leads to an acute fissure.
The perianal fistulas consists in the formation of a tube-shaped canal that opens 1 10 between the anal canal on one side and, usually, the perianal skin on the other side.
Even for these proctological diseases it is important to maintain a proper daily hygiene through the use of specific cleansers.
DISCLOSURE OF INVENTION
The composition object of the invention is proposed in the form of rinse-off foam for 1 15 topical use, indicated for the daily cleansing of the anal mucosa in particular after surgical interventions and/or in the presence of proctological diseases in order to maintain a proper hygiene in the area. To date the liquid soaps on the market, in order to carry out their cleansing action, must be applied by the user through a mechanical rubbing action on the inflamed and
120 injured mucosa. This rubbing action turns out to be painful in the presence of proctological diseases or after surgery. The foam formulation object of this invention is dispensed directly on the anal mucosa and it carries out its cleansing action by staying in place for about 30 seconds with no need to rub. Consequently, the formulation gently cleanses the inflamed surface and carries out a refreshing action
125 of the anal mucosa, thus avoiding an increase of the irritation and giving a sensation of immediate relief.
Bisabolol, one of the most important active ingredients of camomile (Matricaria recutita), has known calming and soothing properties (Guy P.P. Kamatou, Alvaro M. Viljoen. A review of the application and pharmacological properties of bisabolol and 130 bisabolol-rich ils. Journal of the American Oil Chemists ' Society, Volume 87, Issue 1, January 2010, Pages 1-7).
Escin is a mixture of saponins (terpene glycosides) extracted from the Aesculus hippocastanum with soothing, anti-edemigenous and vasoprotective action (A. Bruni. Farmacognosia Generale e Applicata. Piccin Nuova Libraria, 1999, p.339).
135 The anti-edemigenous and soothing activity of escin is due to its action on the vascular walls. In case of increased permeability due to inflammation, escin reduces the exudation, by limiting the extravasation of liquids in the tissue and by accelerating the absorption of the exiting edema. Escin increases the resistance of the involved capillaries, by changing their permeability, thereby reducing the passage of
140 liquids from capillaries to tissues.
The β-escin, in particular, is considered the main molecule responsible for the vasoprotective effects with a trophic effect on the microcirculation (Cesare R. Sirtori. Aescin: pharmacology, pharmacokinetics and therapeutic profile. Pharmacological Research Volume 44, Issue 3, September 2001, Pages 183-193).
145 The extract of Calendula officinalis is rich in triterpenes, flavonoids, polysaccharides, carotenes and phytosterols. It has remarkable soothing properties thanks to its unsaponifiable component constituted by flavonoids and mucilages. The active ingredients of the extract of Calendula officinalis, the flavonoids in particular, have a soothing effect on the inflamed and sensitive skin, stimulate the re-
150 epithelialization, accelerate the epidermal turn-over and promote the activity of the fibroblasts of the dermis by helping the synthesis of collagen (Leila Maria Leal Parente, Ruy de Souza Lino Junior, Leonice Manrique Faustino Tresvenzol, Marina Clare Vinaud, Jose Realino de Paula, and Neusa Margarida Paulo. Wound Healing and Anti-Inflammatory Effect in Animal Models of Calendula
155 officinalis L. growing in Brazil. Evidence-Based Complementary and Alternative Medicine, Volume 2012).
The extract of Centella asiatica contains many active ingredients, such as tannins, flavonoids, sugars, free acids and terpenes with important antioxidant, wound healing, vasoprotective functions. It has been demonstrated that Centella asiatica 160 improves the microcirculation, capillary flow and vascular tone, and reinforces the connective tissue of the perivascular amorphous substrate even in the case of hemorrhoids (MacKay D. Hemorrhoids and varicose veins: a review of treatment options. Alternative Medicine Review: a Journal of Clinical Therapeutic 2001, 6(2): 126-140).
165 Sweet almond oil contains many vitamins (A and B), carbohydrates, proteins and minerals, and has emollient, softening, soothing and nourishing properties. It is useful for softening the skin, for the treatment of redness and cracking, for the protection of the delicate skin and for helping to reduce the scars (Ahmad Z. The uses and properties of almond oil. Plastic and Reconstructive Surgery, Salisbury General 170 Hospital, Salisbury, Wiltshire, UK. Complement Ther Clin Pract. 2010 Feb; 16(1): 10-2).
Sodium lauroyl sarcosinate, also known as sarkosyl, is an anionic surfactant with excellent cleaning properties (Lu Yun Chen Yanni Wu Hao Xiao Shenxiu. Sodium Lauroyl Sarcosinate. Fine and Specialty Chemicals 2001 -13).
175 Cocamidopropyl hydro ysultaine and sodium cocoamphoacetate both belong to the class of amphoteric surfactants. This type of surfactants have less cleansing power and less foaming characteristics than the other types of surfactants, but they are less aggressive and are irritating in a limited way (Blake-Has kins, JC, Scala, D, Rhein, LD, Robbins, CR. Predicting surfactant irritation from swelling response of a
180 collagen film. J Soc Cosmet Chem 37: 199-210, 1986).
Cocamidopropyl hydroxysultaine is used as a foam booster, viscosity builder and antistatic agent (Guin JD. Reaction to cocamidopropyl hydroxysultaine, an amphoteric surfactant and conditioner. Contact Dermatitis 42 (5): 284, 2000).
Sodium cocoamphoacetate, derived from coconut oil, has a foam booster and
185 conditioning power. Thanks to its sweetness and its ability to promote the "sliding" of the product on the skin, it makes the product more easy to apply and rinse.
The action of amphoteric surfactants on the damaged skin and mucosa is less aggressive than that of anionic surfactants, for this reason the two compounds are mixed together in the formulation. 190 Menthyl lactate is an ester obtained from two molecules of natural origin, menthol and lactic acid.
Its component in lactic acid maintains the pH of the skin to physiological levels. The menthol stimulates the cold receptors of the skin.
Since it is a derivative of menthol, its refreshing action is more delicate and therefore 195 more pleasant (XIE Wei-yue, SHE Guang-qian, FENG Zhang-ming, NIE Hui, JIANG You-qing. Synthesis of L-menthyl lactate and its applications in personal care products. China Surfactant Detergent & Cosmetics, 2009-04). It does not change the skin temperature, but gives a sensation of natural freshness.
The peppermint oil is used, in association with methyl lactate, because of its delicate 200 refreshing action (Damonte SP, Selem C, Parente ME, Ares G, Manzoni AV.
Freshness evaluation of refreshing creams: influence of two types of peppermint oil and emulsion formulation. J Cosmet Sci. 2011 Nov-Dec;62(6):525-33).
Chlorhexidine digluconate carries out a preservative action thanks to its antiseptic, disinfectant, bacteriostatic and fungistatic properties. Chlorhexidine digluconate is a 205 good alternative to the available antiseptics for the skin, since it has a fast broad- spectrum antimicrobial action, with an extremely low potential to stimulate the skin reactions {Rosenberg A, Alatary SD, Peterson AF. Safety and efficacy of the antiseptic chlorhexidine gluconate. Surgery, Gynecology & Obstetrics 1976, 143(5): 789-92).
210 MODE FOR CARRYING OUT THE INVENTION
The foam formulation is dispensed through the help of a gas mixture (n-butane, isobutane, propane), which allows the application of the product directly on the area to be cleansed, with no need to touch the inflamed and/or damaged surface. The composition according to the invention contains:
- from 0.05% to 0.5% of bisabolol
- from 0.01 % to 0.5% of escin
from 0.1 % to 5% of Calendula officinalis glycolic extract
from 0.1%) to 10% of Centella asiatica glycolic extract
- from 0.005% to 0.2% of sweet almond oil
- from 1 % to 40% of sodium lauroyl sarcosinate
from 1% to 15%) of cocamidopropyl hydroxysultaine
from 1%) to 10%) of sodium cocoamphoacetate
- from 0.01%) to 0.5% of menthyl lactate
from 0.05%) to 0.5%> of peppermint essential oil
- from 0.1%) to 1% of chlorhexidine digluconate
- from 0.1 % to 10% of glycerin
- from 0.1% to 2% of PEG- 12 dimethicone
- from 0.1 % to 2% of citric acid
- from 4%) to 10%> of mixture of n-butane, isobutane and propane
- from 20% to 60% of water
A particularly preferred example for a composition in the form of rinse-off foam for topical use, indicated for the cleansing of the anal mucosa contains the following substances:
- 0.10% di bisabolol
- 0.05% of escin
1.00% of Calendula officinalis glycolic extract
1.00%) of Centella asiatica glycolic extract 0.01% of sweet almond oil
20.00% of sodium lauroyl sarcosinate
8.00% of cocamidopropyl hydroxysultaine,
8.00% of sodium cocoamphoacetate
0.15% of menthyl lactate
0.20% of essential oil
0.45% of chlorhexidine digluconate
5.00% of glycerin
0.45% of PEG- 12 dimethicone
0.32% of citric acid
7.00% of mixture of n-butane, isobutane and propane 48.27% of water

Claims

1. Composition comprising bisabolol, escin, Calendula officinalis glycolic extract, 255 Centella asiatica glycolic extract, sweet almond oil, menthyl lactate, peppermint essential oil, chlorhexidine digluconate, glycerin, in the following concentrations:
- bisabolol in a quantity comprised between 0.05% and 0.5%;
- escin in a quantity comprised between 0.01 % and 0.5%;
- Calendula officinalis glycolic extract in a quantity comprised between 0.1 % and 260 5.0%;
- Centella asiatica glycolic extract in a quantity comprised between 0.1 % and 10%;
- sweet almond oil in a quantity comprised between 0.005% and 0.2%;
- menthyl lactate in a quantity comprised between 0.01% and 0.5%;
265 - peppermint essential oil in a quantity comprised between 0.05% and 0.5%;
- chlorhexidine digluconate in a quantity comprised between 0.1 % and 1 %;
- glycerin in a quantity comprised between 0.1 % and 10%.
2. Composition, as claimed in claim 1, in the form of rinse-off foam for topical use.
3. Composition, as claimed in claims 1 and 2, for the cleansing of the anal mucosa in the presence of proctologic pathologies and/or after surgical interventions.
4. Composition, as claimed in claims 1, 2 and 3, which is directly dispensed on the anal mucosa through the help of a gas mixture and which cleanses by staying in place for about 30 seconds, with no need to rub.
5. Composition, as claimed in claims 1, 2, 3 and 4, containing:
- 0.10% of bisabolol;
- 0.05% of escin; 1.00% of Calendula officinalis glycolic extract;
1.00% of Centella asiatica glycolic extract;
0.01 % of sweet almond oil;
20.00% of sodium lauroyl sarcosinate;
8.00% of cocamidopropyl hydroxysultaine;
8.00% of sodium cocoamphoacetate;
0.15% of menthyl lactate;
0.20% of peppermint essential oil;
0.45% of chlorhexidine digluconate;
5.00% of glycerin;
0.45% of PEG- 12 dimethicone;
0.32% of citric acid;
7.00% of n-butane, isobutane, propane mixture; 48.27% of water.
PCT/IB2013/002476 2012-11-19 2013-11-07 Composition of a cleansing foam based on natural extracts for the cleansing of the anal area WO2014076533A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITBO2012A000631 2012-11-19
IT000631A ITBO20120631A1 (en) 2012-11-19 2012-11-19 COMPOSITION OF A DETERGENT FOAM BASED ON NATURAL EXTRACTS FOR CLEANSING THE PERIANAL AREA.

Publications (1)

Publication Number Publication Date
WO2014076533A1 true WO2014076533A1 (en) 2014-05-22

Family

ID=48047051

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2013/002476 WO2014076533A1 (en) 2012-11-19 2013-11-07 Composition of a cleansing foam based on natural extracts for the cleansing of the anal area

Country Status (2)

Country Link
IT (1) ITBO20120631A1 (en)
WO (1) WO2014076533A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3120841A1 (en) * 2015-07-23 2017-01-25 Christophe Sivanzire Pharmaceutical preparation
US10159637B2 (en) 2016-06-10 2018-12-25 Clarity Cosmetics Inc. Non-comedogenic and non-acnegenic hair and scalp care formulations and method for use
IT201700082270A1 (en) * 2017-07-19 2019-01-19 Ricciuti Laura NEW COMPOSITION MYORLASSANT AND CICATRIZING

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10162058A1 (en) * 2001-12-17 2003-07-24 Cospharcon Gmbh Aqueous cleaning and disinfecting preparation, useful for alleviation of hemorrhoids, intertrigo, decubitus and related disorders, comprises essential oil and cooling components of vegetable or synthetic origin
DE102009013268A1 (en) * 2009-03-05 2010-09-09 Atlanti Chem Gmbh Agent, useful for cleaning anal- and/or genital-area, comprises dry toilet paper and cleaning foam applied on the toilet paper
WO2011154966A1 (en) * 2010-06-10 2011-12-15 Indus Biotech Pvt. Ltd. A method for preparation of highly pure asiaticoside composition from centella asiatica and a method of use thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10162058A1 (en) * 2001-12-17 2003-07-24 Cospharcon Gmbh Aqueous cleaning and disinfecting preparation, useful for alleviation of hemorrhoids, intertrigo, decubitus and related disorders, comprises essential oil and cooling components of vegetable or synthetic origin
DE102009013268A1 (en) * 2009-03-05 2010-09-09 Atlanti Chem Gmbh Agent, useful for cleaning anal- and/or genital-area, comprises dry toilet paper and cleaning foam applied on the toilet paper
WO2011154966A1 (en) * 2010-06-10 2011-12-15 Indus Biotech Pvt. Ltd. A method for preparation of highly pure asiaticoside composition from centella asiatica and a method of use thereof

Non-Patent Citations (18)

* Cited by examiner, † Cited by third party
Title
"Lu Yun Chen Yanni Wu Hao Xiao Shenxiu. Sodium Lauroyl Sarcosinate", FINE AND SPECIALTY CHEMICALS, 13 December 2000 (2000-12-13)
A. BRUNI: "Farmacognosia Generale e Applicata", 1999, PICCIN NUOVA LIBRARIA, pages: 339
AHMAD ET AL: "The uses and properties of almond oil", COMPLEMENTARY THERAPIES IN CLINICAL PRACTICE, ELSEVIER, GB, vol. 16, no. 1, February 2010 (2010-02-01), pages 10 - 12, XP026823340, ISSN: 1744-3881, [retrieved on 20090715] *
AHMAD Z: "The uses and properties of almond oil. Plastic and Reconstructive Surgery, Salisbury General Hospital, Salisbury", COMPLEMENT THER CLIN PRACT., vol. 16, no. 1, February 2010 (2010-02-01), pages 10 - 2
ANON: "The use of N-acyl sarcosinate surfactants in personal care products", May 2000 (2000-05-01), pages 1 - 32, XP055063424, Retrieved from the Internet <URL:http://www.dewolfchem.com/pdf/Chattem_Personal_Care_Brochure.pdf> [retrieved on 20130521] *
BLAKE-HASKINS; JC, SCALA; D, RHEIN; LD, ROBBINS: "CR. Predicting surfactant irritation from swelling response of a collagen film", J SOC COSMET CHEM, vol. 37, 1986, pages 199 - 210
CESARE R., SIRTORI. AESCIN: PHARMACOLOGY, PHARMACOKINETICS AND THERAPEUTIC PROFILE. PHARMACOLOGICAL RESEARCH, vol. 44, no. 3, September 2001 (2001-09-01), pages 183 - 193
DAMONTE SP; SELEM C; PARENTE ME; ARES G; MANZONI AV: "Freshness evaluation of refreshing creams: influence of two types of peppermint oil and emulsion formulation", J COSMET SCI., vol. 62, no. 6, November 2011 (2011-11-01), pages 525 - 33
GUIN JD: "Reaction to cocamidopropyl hydroxysultaine, an amphoteric surfactant and conditioner", CONTACT DERMATITIS, vol. 42, no. 5, 2000, pages 284
GUY P. P. KAMATOU ET AL: "A Review of the Application and Pharmacological Properties of [alpha]-Bisabolol and [alpha]-Bisabolol-Rich Oils", JOURNAL OF THE AMERICAN OIL CHEMISTS' SOCIETY, vol. 87, no. 1, 29 October 2009 (2009-10-29), pages 1 - 7, XP055054582, ISSN: 0003-021X, DOI: 10.1007/s11746-009-1483-3 *
GUY P.P. KAMATOU; ALVARO M VILJOEN: "A review of the application and pharmacological properties ofbisabolol and bisabolol-rich oils", JOURNAL OF THE AMERICAN OIL CHEMISTS' SOCIETY, vol. 87, no. 1, January 2010 (2010-01-01), pages 1 - 7
LEILA MARIA LEAL PARENTE; RUY DE SOUZA LINO JUNIOR; LEONICE MANRIQUE FAUSTINO TRESVENZOL; MARINA CLARE VINAUD; JOSE REALINO DE PAU: "Wound Healing and Anti-Inflammatory Effect in Animal Models of Calendula officinalis L. growing in Brazil", EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, vol. 2012
MACKAY D J: "Hemorrhoids and varicose veins: A review of treatment options", ALTERNATIVE MEDICINE REVIEW, THORNE RESEARCH INC., SANDPOINT, US, vol. 6, no. 2, 2001, pages 126 - 140, XP009095077, ISSN: 1089-5159 *
MACKAY D: "Hemorrhoids and varicose veins: a review of treatment options", ALTERNATIVE MEDICINE REVIEW: A JOURNAL OF CLINICAL THERAPEUTIC, vol. 6, no. 2, 2001, pages 126 - 140
PARENTE ET AL.: "Wound Healing and Anti-Inflammatory Effect in Animal Models of Calendula officinalis L. Growing in Brazil", EVID BASED COMPLEMENT ALTERNAT MED, 24 January 2012 (2012-01-24), XP002720038, Retrieved from the Internet <URL:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3270572/> [retrieved on 20140210], DOI: 10.1155/2012/375671 *
ROSENBERG A; ALATARY SD; PETERSON AF: "Safety and efficacy of the antiseptic chlorhexidine gluconate", SURGERY, GYNECOLOGY & OBSTETRICS, vol. 143, no. 5, 1976, pages 789 - 92
SIRTORI C R: "Aescin: Pharmacology, Pharmacokinetics, and Therapeutic Profile", PHARMACOLOGICAL RESEARCH, ACADEMIC PRESS, LONDON, GB, vol. 44, no. 3, 2001, pages 183 - 193, XP003005995, ISSN: 1043-6618, DOI: 10.1006/PHRS.2001.0847 *
XIE WEI-YUE; SHE GUANG-QIAN; FENG ZHANG-MING; NIE HUI; JIANG YOU-QING: "Synthesis of L-menthyl lactate and its applications in personal care products", CHINA SURFACTANT DETERGENT & COSMETICS, 4 December 2008 (2008-12-04)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3120841A1 (en) * 2015-07-23 2017-01-25 Christophe Sivanzire Pharmaceutical preparation
US10159637B2 (en) 2016-06-10 2018-12-25 Clarity Cosmetics Inc. Non-comedogenic and non-acnegenic hair and scalp care formulations and method for use
US10813872B2 (en) 2016-06-10 2020-10-27 Clarity Cosmetics Inc. Hair and scalp formulations
US11160746B2 (en) 2016-06-10 2021-11-02 Clarity Cosmetics Inc. Non-comedogenic and non-acnegenic hair and scalp care formulations and method for use
IT201700082270A1 (en) * 2017-07-19 2019-01-19 Ricciuti Laura NEW COMPOSITION MYORLASSANT AND CICATRIZING

Also Published As

Publication number Publication date
ITBO20120631A1 (en) 2014-05-20

Similar Documents

Publication Publication Date Title
Fernandes et al. Children and newborn skin care and prevention
US20080038219A1 (en) Novel Composition for a Topical Skin Treatment Base and Medicated Applications Thereof
Ramos-e-Silva et al. Acne vulgaris: review and guidelines.
WO2014076533A1 (en) Composition of a cleansing foam based on natural extracts for the cleansing of the anal area
TWI495476B (en) A composition and use thereof in the treatment of anal rhagades
Gonçalves et al. Dermocosmetic care for rosacea
BR112014000795B1 (en) Cosmetic and / or dermatological use of oligosaccharide compounds in the prevention and treatment of stretch marks.
KR20210119188A (en) Feminine vulva cleanser and method for producing the same
TW201416071A (en) Antiseptic, antiseborrheic and exfoliating composition to remove or prevent acne
JP2000511168A (en) Esters of vitamin E as a product for topical application
CN110339249B (en) Traditional Chinese medicine composition for treating hemorrhoids and anal fissure as well as preparation method and application thereof
ES2624743T3 (en) Procedure of cosmetic treatment of redness
CN101313940A (en) Traditional Chinese medicine nourishing skin-protection plaster
CN112770765A (en) Composition for preventing and/or treating urogenital mucosa
CN105963367A (en) Preoperative nursing gel for anorectal surgery and preparation method of gel
US8475852B2 (en) Topical therapeautic composition and palliative treatment method
Shrivastava et al. Clinical efficacy of a dual action, topical anti-edematous and antiinflammatory device for the treatment of external hemorrhoids
Dębowska et al. Evaluation of the efficacy and tolerability of mandelic acid-containing cosmetic formulations for acne skin care
ES2613950T3 (en) Oleuropein compositions for wound healing and ulcers in the elderly and / or diabetics
EP3461490B1 (en) Pharmaceutical composition for treating hemorrhoidal disaese
BR102017003316A2 (en) topical composition and method for preventing, reducing or treating greasiness and acne
US8741360B2 (en) Topical therapeutic composition and palliative treatment method
RU2722823C2 (en) Cosmetic composition for treating and preventing acne on skin
Upanal Evaluation of the Efficacy of Panchavalkala Lepa and Kashaya in the Management of Mukha Dushika WSR to Acne Vulgaris
EP2490666A1 (en) Lotion for cleaning human anorectal area

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13821512

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 13821512

Country of ref document: EP

Kind code of ref document: A1